U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07078682) titled 'An Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms' on July 11.
Brief Summary: This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Uterine Fibroids
Leiomyoma...